Compare SKWD & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SKWD | RGC |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | Hong Kong |
| Employees | 611 | N/A |
| Industry | Property-Casualty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.1B |
| IPO Year | 2022 | 2020 |
| Metric | SKWD | RGC |
|---|---|---|
| Price | $60.59 | $10.00 |
| Analyst Decision | Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $70.73 | N/A |
| AVG Volume (30 Days) | ★ 309.5K | 251.4K |
| Earning Date | 11-05-2026 | 10-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.81 | N/A |
| EPS | ★ 2.17 | N/A |
| Revenue | ★ $1,416,541,000.00 | N/A |
| Revenue This Year | $39.34 | N/A |
| Revenue Next Year | $6.68 | N/A |
| P/E Ratio | $28.14 | ★ N/A |
| Revenue Growth | ★ 23.16 | N/A |
| 52 Week Low | $40.60 | $4.51 |
| 52 Week High | $65.69 | $69.00 |
| Indicator | SKWD | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 65.66 | 81.14 |
| Support Level | $55.18 | $4.97 |
| Resistance Level | $63.49 | $29.26 |
| Average True Range (ATR) | 1.41 | 1.14 |
| MACD | 0.61 | 0.33 |
| Stochastic Oscillator | 92.94 | 80.23 |
Skyward Specialty Insurance Group Inc is a specialty insurance company that offers a suite of specialized insurance solutions across specialty property and casualty markets on a non-admitted and admitted basis. Its portfolio of insurance offerings covers a wide variety of risks, including general liability, commercial auto, group accident and health, property, agriculture, credit, surety, and workers' compensation, among others. Geographically, the group mainly operates in the United States.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.